ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 6645

$3.77M Total Retail Price of All Prescriptions

Rank: 15 out of 6645

585 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 585 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 31,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

60% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$118 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NEXIUM 1,480 1,445 1 40
LIDODERM 1,400 1,378 2 53
CELEBREX 1,090 1,068 3 54
CRESTOR 965 911 4 34
CREON 957 940 10 5 114
CLOPIDOGREL 855 826 6 36
IBANDRONATE SODIUM 767 763 10 7 147
AZOR 714 687 10 8 152
LOVAZA 699 681 9 68
ZENPEP 699 690 10 9 210
ATORVASTATIN CALCIUM 686 683 11 10
DONEPEZIL HCL 620 620 12 27
OMEPRAZOLE 531 519 13 6
PLAVIX 526 514 14 49
AMLODIPINE BESYLATE 521 490 15 2
LEVOFLOXACIN 479 450 16 83
MELOXICAM 451 438 17 46
BYSTOLIC 424 416 18 110
CARVEDILOL 416 404 19 25
JANUVIA 405 366 20 38
DIOVAN 403 390 21 19
GLYBURIDE-METFORMIN HCL 400 360 R 22 95
METFORMIN HCL 386 376 23 7
VOLTAREN 385 371 24 108
GLIMEPIRIDE 377 361 25 47
JANUMET 333 322 26 132
EVISTA 329 329 27 90
TAMSULOSIN HCL 324 324 28 22
EXFORGE 314 310 29 155
TRIAMCINOLONE ACETONIDE 290 277 30 55
ACTONEL 290 290 30 92
BONIVA 275 275 10 32 191
BACLOFEN 270 258 33 100
VESICARE 267 266 34 148
ZOLPIDEM TARTRATE 251 233 35 17
AMLODIPINE BESYLATE-BENAZEPRIL 251 251 35 97
SINGULAIR 251 251 35 76
LYRICA 247 234 38 127
SIMVASTATIN 241 240 39 1
BENICAR 235 231 40 84
LEVOTHYROXINE SODIUM 233 231 41 4
COREG CR 232 231 42 242
DIOVAN HCT 222 213 43 64
ISOSORBIDE MONONITRATE ER 217 217 44 66
AVODART 214 214 45 99
MEGESTROL ACETATE 211 211 R 46 104
RAPAFLO 209 209 47 246
TRAMADOL HCL 199 190 48 30
DOXAZOSIN MESYLATE 198 198 49 81
ALENDRONATE SODIUM 193 193 50 14
GABAPENTIN 189 180 51 18
DEXILANT 166 164 52 102
RESTASIS 164 160 53 311
KETOCONAZOLE 161 158 54 196
FLUOCINONIDE 161 156 54 130
ATENOLOL 161 156 54 8
ACETAMINOPHEN-CODEINE 157 153 S3 57 80
COMBIVENT 153 151 58 174
AMITIZA 151 151 59 245
MONTELUKAST SODIUM 149 149 60 128
LOSARTAN POTASSIUM 147 125 61 12
PATADAY 142 141 62 183
NASONEX 139 136 63 126
TRIAMTERENE-HCTZ 137 134 64 52
HYDROCODONE-ACETAMINOPHEN 133 120 S3 65 5
LEVOCETIRIZINE DIHYDROCHLORIDE 132 128 66 241
CYMBALTA 128 128 67 78
ONGLYZA 126 106 68 168
ADVAIR DISKUS 121 121 69 45
SERTRALINE HCL 120 118 70 43
LIPITOR 116 115 71 69
TRIBENZOR 115 115 72 257
EFFIENT 113 113 73 261
METOCLOPRAMIDE HCL 113 112 73 120
ATELVIA 111 110 75 91
FLECTOR 110 110 76 230
METOPROLOL SUCCINATE 98 98 77 24
CLONIDINE HCL 97 93 78 56
KOMBIGLYZE XR 92 91 79 297
SPIRIVA 92 91 79 65
IBUPROFEN 91 90 81 42
ACARBOSE 89 74 82 211
LANTUS SOLOSTAR 87 77 83 139
ACIPHEX 86 83 84 167
TRILIPIX 85 69 85 178
LANSOPRAZOLE 85 85 85 163
EXELON 81 81 87 149
AMOXICILLIN 80 75 88 107
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 89 62
CEPHALEXIN 76 72 90 111
BENICAR HCT 76 70 90 158
LANTUS 74 63 92 50
TRADJENTA 68 55 93 401
ALLOPURINOL 63 63 94 31
PREMPRO 59 59 R 95 369
FLUTICASONE PROPIONATE 58 58 96 26
INSULIN SYRINGE 58 50 96 61
NIFEDIPINE ER 58 58 96 82
DEXTROSE WITH SODIUM CHLORIDE 56 56 99 464
NAPHAZOLINE HCL 54 52 100 215
PILOCARPINE HCL 53 53 101 450
AMIODARONE HCL 52 52 102 160
DIPHENOXYLATE-ATROPINE 52 51 102 214
NAMENDA 51 51 104 41
FENOFIBRATE 51 51 104 74
EVOXAC 50 50 106 750
PROAIR HFA 50 50 106 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.